Literature DB >> 31456370

Dose Coronary Angiography Suffice for Assessment of Intermediate Coronary Stenosis?

Sung Gyun Ahn1, Sang Jun Lee2.   

Abstract

Entities:  

Year:  2019        PMID: 31456370      PMCID: PMC6813155          DOI: 10.4070/kcj.2019.0227

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


× No keyword cloud information.
Intermediate coronary stenosis on angiography is mostly defined by the diameter stenosis of 40% to 70%.1) Coronary angiography commonly fails to identify the real hemodynamic significance of intermediate coronary stenosis as it has the fundamental drawbacks of being a luminogram. This brings on frequent over- or underestimation of stenosis severity due to the eccentricity of atheroma and vascular remodeling with significant intra- and inter-observer variability of visual estimation. Moreover, only a small number of patients in the catheterization laboratory have a noninvasive myocardial ischemia test before coronary angiography.2) For these reasons, intermediate coronary stenosis on angiography remained a therapeutic dilemma for cardiologists. Fortunately, in the past 2 decades, the use of intracoronary physiological index such as fractional flow reserve (FFR) has been expanded to complement the diagnostic capability of coronary angiography.3)4) Indeed, FFR can recategorize approximately half of intermediate lesions, defined by 50–70% luminal stenosis into hemodynamically insignificant ones with FFR >0.80.5) Whether moderately stenotic lesions can induce myocardial ischemia is determined by a complex interplay among coronary flow velocity, degree of stenosis, plaque characteristics, and microvascular function.6) Determinants for positive FFR in intermediate lesions include age, their location, their subtended myocardial mass, the presence of concomitant proximal or distal stenoses, diffuseness of atheroma, the presence of high-risk plaque features, or microvascular integrity.5)6)7) Thus, adjunctive physiological assessment for intermediate coronary stenosis is requisite in decision making for percutaneous coronary intervention (PCI) given that the long-term efficacy and safety of physiology-guided deferred PCI or revascularization strategy have been established from multiple randomized controlled trials.3)4) In this issue of the Korean Circulation Journal, Kim et al.8) raised critical issues regarding the underutilization of physiology in PCI for intermediate coronary stenosis. From a nationwide, standardized database for PCI case analysis of 92 hospitals,2)9) the authors reported that an overall rate of physiology-guided PCI for intermediate lesions is remarkably low, up to 11.5%. The impediments to higher FFR performance in PCI for intermediate lesions vary, including a lack of facilities for FFR measurement, the entrenched oculostenotic reflex of treating physicians, additional medical cost, and technical issues such as hyperemic agents. Most importantly, as the authors stated in the article, limited reimbursements by National Health Insurance for FFR measurement hamper its widespread use in PCI for intermediate coronary stenosis. Weaknesses of this article include potential underreported FFR use due to selective participating institutes, a lack of information on the rate of FFR-guided deferred PCI for intermediate lesions, and a lack of noninvasive correlative studies. Notwithstanding, this kind of real-world data registries could fill the gap between randomized control trials and our daily practice.9)10) Additionally, this real-world evidence would be the cornerstone for future research, improvement of physicians' practice pattern, and national healthcare policy amendment.9) Coronary angiography alone is not sufficient for the proper assessment of intermediate coronary stenosis. Noninvasive coronary computed tomography angiography, and intracoronary imaging modalities such as intravascular ultrasound, optical coherence tomography or intravascular near-infrared spectroscopy may help recognize event-prone high-risk nonobstructive plaque.7) Intermediate coronary stenosis is likely the most needed but underused for intracoronary imaging and physiology. Their judicious integration into our everyday practice in the catheterization laboratory would help us provide evidence-based best medical care for patients with intermediate coronary stenosis.
  10 in total

1.  Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial.

Authors:  Frederik M Zimmermann; Angela Ferrara; Nils P Johnson; Lokien X van Nunen; Javier Escaned; Per Albertsson; Raimund Erbel; Victor Legrand; Hyeong-Cheol Gwon; Wouter S Remkes; Pieter R Stella; Pepijn van Schaardenburgh; G Jan Willem Bech; Bernard De Bruyne; Nico H J Pijls
Journal:  Eur Heart J       Date:  2015-09-23       Impact factor: 29.983

Review 2.  Assessment of intermediate severity coronary lesions in the catheterization laboratory.

Authors:  Jonathan Tobis; Babak Azarbal; Leo Slavin
Journal:  J Am Coll Cardiol       Date:  2007-02-09       Impact factor: 24.094

3.  Visual-functional mismatch between coronary angiography and fractional flow reserve.

Authors:  Seung-Jung Park; Soo-Jin Kang; Jung-Min Ahn; Eun Bo Shim; Young-Tae Kim; Sung-Cheol Yun; Haegeun Song; Jong-Young Lee; Won-Jang Kim; Duk-Woo Park; Seung-Whan Lee; Young-Hak Kim; Cheol Whan Lee; Gary S Mintz; Seong-Wook Park
Journal:  JACC Cardiovasc Interv       Date:  2012-10       Impact factor: 11.195

4.  Discordance Between Fractional Flow Reserve and Coronary Flow Reserve: Insights From Intracoronary Imaging and Physiological Assessment.

Authors:  Sung Gyun Ahn; Jon Suh; Olivia Y Hung; Hee Su Lee; Yasir H Bouchi; Wenjie Zeng; Rounak Gandhi; Parham Eshtehardi; Bill D Gogas; Habib Samady
Journal:  JACC Cardiovasc Interv       Date:  2017-05-22       Impact factor: 11.195

5.  Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.

Authors:  Panagiotis Xaplanteris; Stephane Fournier; Nico H J Pijls; William F Fearon; Emanuele Barbato; Pim A L Tonino; Thomas Engstrøm; Stefan Kääb; Jan-Henk Dambrink; Gilles Rioufol; Gabor G Toth; Zsolt Piroth; Nils Witt; Ole Fröbert; Petr Kala; Axel Linke; Nicola Jagic; Martin Mates; Kreton Mavromatis; Habib Samady; Anand Irimpen; Keith Oldroyd; Gianluca Campo; Martina Rothenbühler; Peter Jüni; Bernard De Bruyne
Journal:  N Engl J Med       Date:  2018-05-22       Impact factor: 91.245

6.  Prognostic Implications of Plaque Characteristics and Stenosis Severity in Patients With Coronary Artery Disease.

Authors:  Joo Myung Lee; Ki Hong Choi; Bon-Kwon Koo; Jonghanne Park; Jihoon Kim; Doyeon Hwang; Tae-Min Rhee; Hyung Yoon Kim; Hae Won Jung; Kyung-Jin Kim; Kawase Yoshiaki; Eun-Seok Shin; Joon-Hyung Doh; Hyuk-Jae Chang; Yun-Kyeong Cho; Hyuck-Jun Yoon; Chang-Wook Nam; Seung-Ho Hur; Jianan Wang; Shaoliang Chen; Shoichi Kuramitsu; Nobuhiro Tanaka; Hitoshi Matsuo; Takashi Akasaka
Journal:  J Am Coll Cardiol       Date:  2019-05-21       Impact factor: 24.094

7.  In-hospital outcome differences between transradial and transfemoral coronary approaches: Data from the Korean percutaneous coronary intervention registry.

Authors:  Sung Gyun Ahn; Jun-Won Lee; Young Jin Youn; Seung-Hwan Lee; Jang Hyun Cho; Woong Chol Kang; Jong-Pil Park; Won-Yong Shin; Seong-Hoon Lim; Yu Jeong Choi; Kyungsoo Kim; Do-Sun Lim; Woojung Chun; Ju Han Kim; Junghan Yoon
Journal:  Catheter Cardiovasc Interv       Date:  2019-01-02       Impact factor: 2.692

8.  The Current Status of Intervention for Intermediate Coronary Stenosis in the Korean Percutaneous Coronary Intervention (K-PCI) Registry.

Authors:  Jin Ho Kim; Woonggil Choi; Ki Chang Kim; Chang Wook Nam; Bum Kee Hong; June Hong Kim; Doo Soo Jeon; Jang Whan Bae; Sang Hyun Kim; Keon Woong Moon; Byung Ryul Cho; Doo Il Kim; Jae Sik Jang
Journal:  Korean Circ J       Date:  2019-06-05       Impact factor: 3.243

9.  The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry.

Authors:  Jae-Sik Jang; Kyoo-Rok Han; Keon-Woong Moon; Dong Woon Jeon; Dong-Ho Shin; Jung-Sun Kim; Duk-Woo Park; Hyun-Jae Kang; Juhan Kim; Jang-Whan Bae; Seung-Ho Hur; Byung Ok Kim; Donghoon Choi; Hyeon-Cheol Gwon; Hyo-Soo Kim
Journal:  Korean Circ J       Date:  2017-05-25       Impact factor: 3.243

10.  The Practice Pattern of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry.

Authors:  Hyeon-Cheol Gwon; Dong Woon Jeon; Hyun-Jae Kang; Jae-Sik Jang; Duk-Woo Park; Dong-Ho Shin; Keon-Woong Moon; Jung-Sun Kim; Juhan Kim; Jang-Whan Bae; Seung-Ho Hur; Byung Ok Kim; Donghoon Choi; Kyoo-Rok Han; Hyo-Soo Kim
Journal:  Korean Circ J       Date:  2017-05-25       Impact factor: 3.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.